Scientific Director, Material Science
Bristol-Myers Squibb/Translational Sciences
Princeton, New Jersey
Jonathan Haulenbeek received his PhD in Analytical Chemistry from Drexel University. He has 20 years experience in the Biopharma industry, including small and large molecule CMC, regulated bioanalysis, protein chemistry and biomarker assay development. He currently leads a team in translational sciences and diagnostics that develops protein reagents and prototype assays in support of biomarker and diagnostic assays. His team also utilizes novel automation workflows that enable high throughput sample analysis and increased assay robustness for various bioanalytical assay formats.
Epitope Specific Concentration Analysis of Recombinant Calibrators for Biomarker LBAs
Wednesday, October 25, 2023
3:15 PM – 3:30 PM ET